Featured Post

Latest Gold News

Fed doves supporting gold Stronger rand crushing South African miners Economic power could shift further East with Hong Kong gold exch...

Tuesday, January 10, 2012

Vale (VALE) (UTIW) (RDK) (REGN) (RMTI) (RSTI) Ratings, Price Targets

Vale (NASDAQ: VALE), UTi Worldwide Inc. (NASDAQ: UTIW), Ruddick Corporation (NYSE: RDK), Regeneron Pharma (NASDAQ: REGN), Rockwell Medical (NASDAQ: RMTI) and Rofin-Sinar Technologies (NASDAQ: RSTI) ratings and price targets.

UTi Worldwide Inc. (UTIW) was downgraded by Zacks Investment Research from a “neutral” rating to an “underperform” rating.

Vale (VALE) was downgraded by HSBC (NYSE:HBC) to a “neutral” rating.

Ruddick Corporation (RDK) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.

Regeneron Pharma (REGN) was upgraded by Robert W. Baird from a “neutral” rating to an “outperform” rating. They have a price target of $81.00 on the firm, up from $56.00.

Rockwell Medical (RMTI) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.

Rofin-Sinar Technologies (RSTI) was upgraded by Zacks Investment Research from an “underperform” rating to a “neutral” rating.

No comments: